Botulinum toxin type A in the treatment of spasticity in cerebral palsy: theoretical and practical foundations of effective therapy

Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2001, Vol 3, Issue 4

Abstract

Spasticity is one of the constituent elements of upper motor neuron syndrome. For now, it is also the only symptom which is pharmacologically treatable. The pathophysiology of spasticity is very complex, and many aspects remain unclear. The great majority of commonly used oral drugs modulate the activity of receptors and/or neurotransmitters at different levels of the central nervous system. This is perhaps the main reason for the limited effectiveness of these drugs in many cases. Recently a new strategy – local injections of botulinum toxin type A (BTX-A) – has been introduced for the treatment of spasticity in cerebral palsy and post-stroke patients. BTX-A is a unique drug that acts at the final stage of the common pathway of pathological information mediated through the peripheral nerves to the muscles (at the motor end plates). Its mode of action is known as “chemical denervation”, which serves to reduce increased muscle tone, improve the range of motions, positioning, function, and promote muscle growth in children. BTX-A was firstly used in post-stroke spasticity patients by Das and Park in 1989, but the best effects have been achieved in cerebral palsy. Accordingly, since 1997 this method has been approved in many European countries and Australia, and the principles governing this treatment strategy were published in the journal “Gait and Posture” in 2000. In the present paper, the author discusses the mechanism of spasticity, the logical approach to therapy, and many practical problems (injection modality, tolerability).

Authors and Affiliations

Jarosław Sławek

Keywords

Related Articles

DRAINING INFECTED NON UNION OF THE DISTAL THIRD OF THE TIBIA. THE USE OF INVAGINATING DOCKING OVER SHORT DISTANCES IN OLDER PATIENTS

SUMMARY BACKGROUND The distal third of the tibia is unique in the sense that it has a minimal muscle cover and consequently the blood supply is easily compromised after a fracture in this area. Infected non union in this...

Appropriateness and effectiveness of physiotherapeutic treatment procedure after tendon transfer in patients with irreversible radial nerve injury

Background. Research conducted by many authors has indicated that if muscles are not re-innervated after radial nerve paralysis, it is necessary to perform a tendon transfer operation. The goal of our study was to evalua...

Tactics of operative procedures and results of treatment patients with coxarthrosis in congenital high luxation of hip joints.

[b]Material and method.[/b] The results of 4 years observation, of the treatment of 14 woman in the average age of 38 years old with 18 hip joints with congenital high luxation are presented.In all cases cementless total...

Małoinwazyjne dostępy operacyjne w endoprotezoplastyce stawu biodrowego.

Sukces operacji zależy od szybkiego powrotu funkcji kończyny. Każde uszkodzenie mięśnia i jego przyczepu wiąże się z osłabieniem jego siły, uszkadza jego prioreceptory co opóźnia przywrócenie sprawności kończyny.Małoinwa...

Ruchomość stawów biodrowych u tancerzy. Doniesienie wstępne.

Wstęp. Celem niniejszej pracy była ocena wpływu tańca na ruchomość stawów biodrowych, a także ocena związku pomiędzy czynnymi ruchami w stawach biodrowych a urazowością u tancerzy, co może być istotne w planowaniu proces...

Download PDF file
  • EP ID EP56180
  • DOI -
  • Views 129
  • Downloads 0

How To Cite

Jarosław Sławek (2001). Botulinum toxin type A in the treatment of spasticity in cerebral palsy: theoretical and practical foundations of effective therapy. Ortopedia Traumatologia Rehabilitacja, 3(4), 541-546. https://europub.co.uk/articles/-A-56180